Navigation Links
Call for Entries - 2008 CURE Extraordinary Healer Award for Oncology Nursing
Date:2/6/2008

Ortho Biotech Products, L. P. Supports Program to Recognize Exemplary Work

BRIDGEWATER, N.J., Feb. 6 /PRNewswire/ -- To recognize the extraordinary commitment of oncology nurses, Ortho Biotech Products, L. P. today announced its support of CURE magazine's 2008 Extraordinary Healer Award for Oncology Nursing, which honors one of the thousands of exceptional oncology nurses who demonstrate daily their unwavering dedication, compassion and helpfulness. Last year, more than 200 cancer patients and survivors nominated their oncology nurse for the first Extraordinary Healer Award, presented by CURE magazine.

Cancer patients and caregivers are asked to submit essays nominating oncology nurses who exemplify these characteristics. Three finalists, and those who nominated them, will be honored at a special reception during the Oncology Nursing Society's Annual Congress in Philadelphia on May 15 at 7pm at the Philadelphia Downtown Marriott. The call for entries is featured in the Winter 2007 and Spring 2008 issues of CURE, a quarterly magazine for cancer patients, survivors and caregivers, as well as the Spring issue of HEAL, a quarterly magazine for cancer survivors. Nominations must be received by April 7, 2008. For more information about the 2008 Extraordinary Healer Award for Oncology Nursing, please visit http://www.curetoday.com.

"Oncology nurses provide a vital service to people affected by cancer, and Ortho Biotech is proud to be part of an effort that recognizes these exemplary professionals," said Craig Tendler, M.D., Vice President, Medical Affairs, Oncology/Nephrology, Ortho Biotech Products, L.P. "Patients rely on a strong network of care while going through cancer treatment, and oncology nurses provide the critical physical and emotional support patients need to complete cancer treatment."

In 2007, CURE received more than 200 essay entries for its inaugural Extraordinary Healer Award for Oncology Nursing, and more than 650 nurses attended the award ceremony at the Oncology Nursing Society's Annual Congress. The winning and finalist essays from 2007 can be read on line at http://www.curetoday.com/healeraward2007.

"The Extraordinary Healer Award has given us the opportunity to give a voice back to our readers, who openly share their admiration and appreciation for their nurses," says Melissa Weber, managing editor of CURE. "The award is a forum for our readers to say thank you, and they're saying it quite eloquently."

About CURE

CURE is a quarterly magazine with an annual Resource Guide and special issue that combines the science and humanity of cancer for those who have to deal with it on a daily basis. CURE provides scientific information in easy-to-understand language for patients, survivors and caregivers. It is published by Dallas-based CURE Media Group, L.P.

About Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients' health. Located in Bridgewater, N.J., Ortho Biotech is an established market leader in Epoetin alfa therapy for anemia management. The company also markets treatments for recurrent ovarian cancer, rejection of transplanted organs and other serious illnesses. For more information, visit http://www.orthobiotech.com.


'/>"/>
SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AAAAI: Call for Entries: Have You Written a Story on Allergic Disease? Win $1000
2. Ten Extraordinary Innovations Line Up For US $100,000 Saatchi & Saatchi Award For World Changing Ideas
3. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
4. Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)
5. Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
6. Rice wins innovation award for international program
7. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
8. Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group
9. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
10. GBC Seeks Nominations for Regions Third Annual Bioscience Awards
11. UCB Crohns Scholarship Program to Award $300,000 to Students with Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... platform specifically designed for life science researchers to analyze and interpret datasets, ... Franklin, who made a major contribution to the discovery of the double-helix ...
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):